{"anticipatedPostingDate":"2026-06","denomUnitsSelected":"Participants","description":"Percentage of patients experiencing grade 3 or higher adverse events will be evaluated according to National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0","reportingStatus":"NOT_POSTED","timeFrame":"Up to 2 years from study entry","title":"Percentage of Patients Experiencing Grade 3 or Higher Adverse Events","type":"SECONDARY"}